Health and Fitness FDA Approves Topamax for Migraine Prevention in Adolescents by Gary Kopycinski on March 28, 2014 Gary Kopycinski Author More in Health and Fitness: On Hantavirus, Park Forest Officials Urge Caution May 18, 2026 Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026 Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026 First approved treatment for ages 12 to 17